Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chemoradiotherapy × CNS × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Thoracic 1 Head & Neck 1 Genitourinary 1 CNS 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 42 Temozolomide 33 Specimen Handling 28 Radiotherapy 18 Radiosurgery 14 pembrolizumab 13 Nivolumab 12 Cyclophosphamide 12 Radiation 11 Biopsy 10 Bevacizumab 10 trametinib 8 Carboplatin 8 fludarabine 7 dinutuximab 7 abemaciclib 7 X-Rays 7 Vincristine 7 Surgical Procedures, Operative 7 Lomustine 7 Irinotecan 7 Ipilimumab 7 Topotecan 6 sargramostim 5 Nuclear Medicine Department, Hospital 5 Doxorubicin 5 mirdametinib 4 lutetium Lu 177 dotatate 4 erdafitinib 4 dabrafenib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07511725 2026-04-06

PRISM

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡